Pharmacological prevention of suicide in patients with major mood disorders

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 10, 2013, Pages 2398-2403

  Rihmer, Zoltan ^a   Gonda, Xenia ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Antidepressants; Bipolar disorder; Completed suicide; Suicide attempt; Suicide prevention; Unipolar major depression

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; FLUOXETINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VALPROATE SEMISODIUM; VENLAFAXINE;

ANXIETY DISORDER; BIPOLAR DEPRESSION; COMORBIDITY; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; HUMAN; MAJOR DEPRESSION; MONOTHERAPY; MOOD DISORDER; MORTALITY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; REVIEW; RISK REDUCTION; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT;

ANTIDEPRESSANTS; BIPOLAR DISORDER; COMPLETED SUICIDE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DSM-IV; ECT; ELECTROCONVULSIVE THERAPY; FDA; FOOD AND DRUG ADMINISTRATION; ODDS RATIO; OR; RANDOMIZED CONTROLLED TRIAL; RCT; SELECTIVE SEROTONIN REUPTAKE INHIBITORS; SSRI; SUICIDE ATTEMPT; SUICIDE PREVENTION; TCA; TRICYCLIC ANTIDEPRESSANT; UNIPOLAR MAJOR DEPRESSION;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; HUMANS; LITHIUM COMPOUNDS; MOOD DISORDERS; SUICIDE;

EID: 84890245279     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.09.009     Document Type: Review

References (64)

1. Ahrens B., Muller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect?. Pharmacopsychiatry 2001, 34:132-136.
2. Akiskal H.S., Benazzi F. Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states?. Psychopathology 2005, 38:273-280.
3. Angst F., Stassen H.H., Clayton P.J., Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. Journal of Affective Disorders 2002, 68:167-181.
4. Angst J., Cui L., Swendsen J., Rothen S., Cravchik A., Kessler R.C., Merikangas K.R. Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. The American Journal of Psychiatry 2010, 167:1194-1201.
5. Baldessarini R.J., Undurraga J., Vázquez G.H., Tondo L., Salvatore P., Ha K., Khalsa H.M., Lepri B., Ha T.H., Chang J.S., Tohen M., Vieta E. Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatrica Scandinavica 2012, 125:293-302.
6. Baldessarini R.J., Tondo L., Davis P., Pompili M., Goodwin F.K., Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disorders 2006, 8:625-639.
7. Bostwick J.M., Pankratz V.S. Affective disorders and suicide risk: a reexamination. American Journal of Psychiatry 2000, 157:1925-1932.
8. Bowden C.L. Pharmacological treatment of bipolar disorder: a review. Bipolar Disorder 2002, 191-221. John Wiley & Sons, Chichester. M. Maj, H.S. Akiskal, J.J. Lopez-Ibor, N. Sartorius (Eds.).
9. Collins J.C., McFarland B.H. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. Journal of Affective Disorders 2008, 107:23-28.
10. Coryell W., Young E.A. Clinical predictors of suicide in primary major depressive disorder. Journal of Clinical Psychiatry 2005, 66:412-417.
11. Cougnard A., Verdoux H., Grolleau A., Moride Y., Begaud B., Tournier M. Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model. Psychological Medicine 2009, 39:1307-1315.
12. Fergusson D., Doucette S., Glass K.C., Shapiro S., Healy D., Hebert P., Hutton B. Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. British Medical Journal 2005, 330:396.
13. Fiedorowicz J.G., Endicott J., Leon A.C., Solomon D.A., Keller M.B., Coryell W.H. Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. The American Journal of Psychiatry 2011, 168:40-48.
14. Gibbons R.D., Brown C.H., Hur K., Marcus S.M., Bhaumik D.K., Erkens J.A., Herings R.M., Mann J.J. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry 2007, 164:1356-1363.
15. Gibbons R.D., Brown C.H., Hur K., Davis J.M., Mann J.J. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Archives of General Psychiatry 2012, 69(6):580-587.
16. Goodwin F.K., Fireman B., Simon G.E., Hunkeler E.M., Lee J., Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA: The Journal of the American Medical Association 2003, 290:1467-1473.
17. Goodwin F.K., Jamison K.R. Manic-Depressive Illness 1990, Oxford University Press, New York.
18. Guzzetta F., Tondo L., Centorrino F., Baldessarini R.J. Lithium treatment reduces suicide risk in recurrent major depressive disorder. The Journal of Clinical Psychiatry 2007, 68:380-383.
19. Jick H., Kaye J.A., Jick S.S. Antidepressants and the risk of suicidal behaviors. Journal of the American Medical Association 2004, 292:338-343.
20. Kapusta N.D., Mossaheb N., Etzersdorfer E., Hlavin G., Thau K., Willeit M., Praschak-Rieder N., Sonneck G., Leithner-Dziubas K. Lithium in drinking water and suicide mortality. British Journal of Psychiatry 2011, 198:346-350.
21. Kessing L.V., Sondergard L., Kvist K., Andersen P.K. Suicide risk in patients treated with lithium. Archives of General Psychiatry 2005, 62:860-866.
22. Khan A., Khan S., Kolts R., Brown W.A. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. The American Journal of Psychiatry 2003, 160:790-792.
23. Khan A., Khan S.R., Leventhal R.M., Brown W.A. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database. International Journal of Neuropsychopharmacology 2001, 4:113-118.
24. Khan A., Warner H.A., Brown W.A. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Archives of General Psychiatry 2000, 57:311-317.
25. Kraus J.E., Horrigan J.P., Carpenter D.J., Fong R., Barrett P.S., Davies J.T. Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy. Journal of Affective Disorders 2010, 120:40-47.
26. Lam R.W., Kennedy S.H., Grigoriadis S., McIntyre R.S., Milev R., Ramasubbu R., Parikh S.V., Patten S.B., Ravindran A.V. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. Journal of Affective Disorders 2009, 117(Suppl. 1):S26-S43.
27. Leon A.C., Keller M.B., Warshaw M.G., Mueller T.I., Solomon D.A., Coryell W., Endicott J. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. American Journal of Psychiatry 1999, 156:195-201.
28. Leon A.C., Solomon D.A., Li C., Fiedorowicz J.G., Coryell W.H., Endicott J., Keller M.B. Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: a 30-year observational study. The American Journal of Psychiatry 2012, 169:285-291.
29. Ludwig J., Marcotte D.E. Anti-depressants, suicide, and drug regulation. Journal of Policy Analysis and Management 2005, 24:249-272.
30. Ludwig M., Marcotte D.E., Norberg K. Antidepressants and suicide. Journal of Health Economics 2009, 28:659-676.
31. Luoma J.B., Martin C.E., Pearson J.L. Contact with mental health and primary care providers before suicide: a review of the evidence. American Journal of Psychiatry 2002, 159:909-916.
32. Menke A., Domschke K., Czamara D., Klengel T., Hennings J., Lucae S., Baune B.T., Arolt V., Müller-Myhsok B., Holsboer F., Binder E.B. Genome-wide association study of antidepressant treatment-emergent suicidal ideation. Neuropsychopharmacology 2012, 37:797-807.
33. Mundo E., Cattaneo E., Russo M., Altamura A.C. Clinical variables related to antidepressant-induced mania in bipolar disorder. Journal of Affective Disorders 2006, 92:227-230.
34. O'Leary D., Paykel E., Todd C., Vardulaki K. Suicide in primary affective disorders revisited: a systematic review by treatment era. Journal of Clinical Psychiatry 2001, 62:804-811.
35. Ohgami H., Terao T., Shiotsuki I., Ishii N., Iwata N. Lithium levels in drinking water and risk of suicide. British Journal of Psychiatry 2009, 194:464-465.
36. Pacchiarotti I., Valenti M., Colom F., Rosa A.R., Nivoli A.M., Murru A., Sanchez-Moreno J., Vieta E. Differential outcome of bipolar patients receiving antidepressant monotherapy versus combination with an antimanic drug. Journal of Affective Disorders 2011, 129:321-326.
37. Pirkis J., Burgess P. Suicide and recency of health care contacts. A systematic review. British Journal of Psychiatry 1998, 173:462-474.
38. Reeves R.R., Ladner M.E. Antidepressant-induced suicidality. CNS Neuroscience & Therapeutics 2010, 16:227-233.
39. Rihmer Z. Suicide risk in mood disorders. Current Opinion in Psychiatry 2007, 20:17-22.
40. Rihmer Z., Akiskal H. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. Journal of Affective Disorders 2006, 94:3-13.
41. Rihmer Z., Angst J. Mood disorders-epidemiology. Kaplan and Sadock's Comprehensive Textbook of Psychiatry 2005, 1575-1582. Lippincott Williams and Wilkins, Philadelphia. B.J. Sadock, V.A. Sadock (Eds.).
42. Rihmer Z., Gonda X. Antidepressant-resistant depression: the role of underlying bipolarity. Depression Research and Treatment 2011, 2011:906462.
43. Rihmer Z., Rutz W. Treatment of attempted suicide and suicidal patients in primary care. Oxford Textbook of Suicidology and Suicide Prevention 2009, 463-470. Oxford University Press, New York. D. Wasserman, C. Wasserman (Eds.).
44. Rouillon F., Serrurier D., Miller H.D., Gerard M.J. Prophylactic efficacy of maprotiline on unipolar depression relapse. Journal of Clinical Psychiatry 1991, 52:423-431.
45. Salvi V., Fagiolini A., Swartz H.A., Maina G., Frank E. The use of antidepressants in bipolar disorder. The Journal of Clinical Psychiatry 2008, 69:1307-1318.
46. Sidor M.M., Macqueen G.M. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis. The Journal of Clinical Psychiatry 2011, 72:156-167.
47. Simon G.E., Savarino J., Operskalski B., Wang P.S. Suicide risk during antidepressant treatment. American Journal of Psychiatry 2006, 163:41-47.
48. Søndergård L., Kvist K., Andersen P.K., Kessing L.V. Do antidepressants precipitate youth suicide?: a nationwide pharmacoepidemiological study. European Child & Adolescent Psychiatry 2006, 15(4):232-240.
49. Sondergard L., Lopez A.G., Andersen P.K., Kessing L.V. Continued antidepressant treatment and suicide in patients with depressive disorder. Archives of Suicide Research 2007, 11:163-175.
50. Sondergard L., Lopez A.G., Andersen P.K., Kessing L.V. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide. Bipolar Disorders 2008, 10:87-94.
51. Thies-Flechtner K., Müller-Oerlinghausen B., Seibert W., Walther A., Greil W. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 1996, 29:103-107.
52. Tiihonen J., Lonnqvist J., Wahlbeck K., Klaukka T., Tanskanen A., Haukka J. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Archives of General Psychiatry 2006, 63:1358-1367.
53. Valenstein M., Kim H.M., Ganoczy D., Eisenberg D., Pfeiffer P.N., Downing K., Hoggatt K., Ilgen M., Austin K.L., Zivin K., Blow F.C., McCarthy J.F. Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment. Journal of Clinical Psychopharmacology 2012, 32:346-353.
54. Valenti M., Pacchiarotti I., Rosa A.R., Bonnin C.M., Popovic D., Nivoli A.M., Murru A., Grande I., Colom F., Vieta E. Bipolar mixed episodes and antidepressants: a cohort study of bipolar I disorder patients. Bipolar Disorders 2011, 13:145-154.
55. Valtonen H.M., Suominen K., Mantere O., Leppamaki S., Arvilommi P., Isometsa E. Suicidal behaviour during different phases of bipolar disorder. Journal of Affective Disorders 2007, 97:101-107.
56. Whittington C.J., Kendall T., Fonagy P., Cottrell D., Cotgrove A., Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004, 363:1341-1345.
57. Yatham L.N., Kennedy S.H., Schaffer A., Parikh S.V., Beaulieu S., O'Donovan C., MacQueen G., McIntyre R.S., Sharma V., Ravindran A., Young L.T., Young A.H., Alda M., Milev R., Vieta E., Calabrese J.R., Berk M., Ha K., Kapczinski F. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disorders 2009, 11:225-255.
58. Yerevanian B.I., Koek R.J., Feusner J.D., Hwang S., Mintz J. Antidepressants and suicidal behaviour in unipolar depression. Acta Psychiatrica Scandinavica 2004, 110:452-458.
59. Yerevanian B.I., Koek R.J., Mintz J. Lithium, anticonvulsants and suicidal behavior in bipolar disorder. Journal of Affective Disorders 2003, 73:223-228.
60. Yerevanian B.I., Koek R.J., Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part 3. Impact of antipsychotics. Journal of Affective Disorders 2007, 103:23-28.
61. Yerevanian B.I., Koek R.J., Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I. Lithium, divalproex and carbamazepine. Journal of Affective Disorders 2007, 103:5-11.
62. Yerevanian B.I., Koek R.J., Mintz J., Akiskal H.S. Bipolar pharmacotherapy and suicidal behavior. Part 2. The impact of antidepressants. Journal of Affective Disorders 2007, 103:13-21.
63. Zimmermann P., Bruckl T., Nocon A., Pfister H., Lieb R., Wittchen H.U., Holsboer F., Angst J. Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Archives of General Psychiatry 2009, 66:1341-1352.
64. Zisook S., Lesser I.M., Lebowitz B., Rush A.J., Kallenberg G., Wisniewski S.R., Nierenberg A.A., Fava M., Luther J.F., Morris D.W., Trivedi M.H. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study. The Journal of Clinical Psychiatry 2011, 72:1322-1332.